Maryia Zhdanava Selected Research

Maryia Zhdanava Research Topics

7	Treatment-Resistant Depressive Disorder 05/2024 - 01/2021
7	Schizophrenia (Dementia Praecox) 01/2022 - 01/2019
5	Crohn Disease (Crohn's Disease) 11/2023 - 01/2023
4	Psoriasis (Pustulosis Palmaris et Plantaris) 12/2024 - 04/2022
3	Ulcerative Colitis 02/2024 - 07/2023
3	Major Depressive Disorder (Major Depressive Disorders) 01/2023 - 01/2017
3	Asthma (Bronchial Asthma) 10/2019 - 01/2018
2	Infections 02/2024 - 11/2023
2	Venous Thromboembolism 08/2023 - 01/2023
2	Atrial Fibrillation 01/2023 - 01/2023
2	Embolism (Embolus) 01/2023 - 01/2023
2	Ischemic Stroke 01/2023 - 01/2023
2	COVID-19 01/2022 - 01/2022
2	Chronic Urticaria 01/2019 - 05/2018
1	Myasthenia Gravis 05/2024
1	Stroke (Strokes) 01/2023
1	Hypersensitivity (Allergy) 10/2019
1	Urticaria (Hives) 05/2018
1	Weight Loss (Weight Reduction) 01/2018
1	Type 2 Diabetes Mellitus (MODY) 01/2018

8	Adalimumab (Humira)FDA Link 01/2024 - 04/2022
7	Ustekinumab (CNTO 1275)FDA Link 01/2024 - 04/2022
6	Antipsychotic Agents (Antipsychotics)IBA 01/2022 - 01/2019
5	EsketamineIBA 05/2024 - 11/2022
5	Omalizumab (Xolair)FDA Link 10/2019 - 01/2018
4	ixekizumabIBA 12/2024 - 04/2022
4	secukinumabIBA 12/2024 - 04/2022
4	Nasal SpraysIBA 05/2024 - 11/2022
4	AnticoagulantsIBA 08/2023 - 01/2023
3	guselkumabIBA 12/2024 - 04/2023
3	Adrenal Cortex Hormones (Corticosteroids)IBA 02/2024 - 03/2018
3	Paliperidone Palmitate FDA Link 01/2021 - 01/2019
3	Antidepressive Agents (Antidepressants)IBA 01/2021 - 01/2017
2	First FillIBA 01/2023 - 01/2023
1	InterleukinsIBA 12/2024
1	Interleukin-17 (Interleukin 17)IBA 12/2024
1	glucose-mannose-glucoseIBA 05/2024
1	Interleukin-12 (IL 12)IBA 01/2024
1	Infliximab (Remicade)FDA Link 01/2023
1	vedolizumabIBA 01/2023
1	Certolizumab Pegol FDA Link 01/2023
1	Tumor Necrosis Factor InhibitorsIBA 01/2023
1	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 01/2023
1	COVID-19 VaccinesIBA 01/2022
1	Risperidone (Risperdal Consta)FDA LinkGeneric 01/2021
1	Nitric Oxide (Nitrogen Monoxide)FDA Link 10/2019
1	Biomarkers (Surrogate Marker)IBA 10/2019
1	CanagliflozinIBA 01/2018
1	Immunoglobulin E (IgE)IBA 01/2018

12	Therapeutics 02/2024 - 03/2018
3	Injections 01/2022 - 01/2021
2	Long-Term Care 10/2021 - 07/2021
1	Self Administration (Administration, Self) 04/2022
1	Drug Therapy (Chemotherapy) 01/2017